“After we handled mice with the AGTR1 inhibitor losartan, we noticed that this commercially out there drug exhibits nice promise in lowering AML growth whereas defending in opposition to chemotherapy-induced cardiotoxicity,” Xunlei Kang, MD, PhD, an affiliate professor of drugs with the College of Missouri Faculty of Medication, stated in a assertion. “This discovering exhibits nice potential to reinforce the success of chemotherapy whereas defending the center.”
“Mouse fashions of leukemia differ from human illness in a number of methods, together with variations within the immune system, the bone marrow microenvironment and responses to remedies,” added first creator Yi Pan, a PhD pupil. “We’ll now rigorously interpret and validate these findings in human research to make sure translational relevance.”
Click on right here for the total examine.
